JR Holding has no information or suspicions of any violations of the MAR Regulations in the context of the issuer or the shares of its portfolio companies, and declares further full cooperation with the KNF and hopes for a quick investigation and approval of the submitted prospectus, the company said.
“The Board of Directors of JR Holding ASI announces that it has become aware of the publication on March 27, 2023, in the afternoon hours, on the website of the Financial Supervisory Commission (hereinafter referred to as the KNF), of a communiqué regarding the initiation of an investigation into the trading in shares of certain companies of which the issuer is a shareholder. With reference to the announcement in question, the issuer’s management board informs that, until the publication of this report, it has not received any correspondence from the Office of the Financial Supervision Commission (hereinafter UKNF) on the matter in question,” the company announced in a press release.
The company on May 14, 2022 submitted an application to the KNF for approval of the prospectus, prepared in connection with the application for admission and introduction to trading on a regulated market operated by the WSE of ordinary, bearer shares, series A, B, C, D and F, it recalled.
“In connection with the pending prospectus approval proceedings, the issuer is in constant contact with the UKNF and is responding to all questions posed by the UKNF. The issuer’s Management Board has no information or suspicions of any violations of the MAR Regulations in the context of the issuer or the shares of its portfolio companies. The issuer’s Management Board declares further full cooperation with the UKNF and hopes that the UKNF will promptly conduct proceedings and approve the issuer’s submitted prospectus,” it further announced.
Yesterday, the UKNF reported that it had passed a resolution to make public information on the initiation of an investigation into the suspected crimes of insider trading and disclosure and manipulation of trading in shares of Ekipa Holding; Impera Capital ASI; Medicofarma Biotech; Medcamp.
JR Holding ASI S.A. is a company listed on the NewConnect market since 2012, focusing on investment activities and involvement in companies in the digital business, renewable energy, gaming, medical, biotechnology and modern media industries. According to its strategy, the company intends to develop its portfolio this year by increasing its diversification, investing in the most promising businesses and launching new investment projects. The company is on its way to a listing on the WSE’s main market.
Source: JR Holding and ISBnews
